Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jun;65(6):2233–2239. doi: 10.1128/iai.65.6.2233-2239.1997

Prelytic and lytic conformations of erythrocyte-associated Escherichia coli hemolysin.

M Moayeri 1, R A Welch 1
PMCID: PMC175308  PMID: 9169756

Abstract

Flow cytometry was developed as a method to assess the conformation of erythrocyte-bound Escherichia coli hemolysin polypeptide (HlyA). Topology of membrane-associated hemolysin (HlyA(E)) was investigated by testing surface accessibility of HlyA regions in lytic and nonlytic bound states, using a panel of 12 anti-HlyA monoclonal antibodies (MAbs). Hemolysin associates nonlytically with erythrocytes at 0 to 2 degrees C. To test the hypothesis that the nonlytic HlyA(E) conformation at 0 to 2 degrees C differs from the lytic conformation at 23 degrees C, MAb epitope reactivity profiles at the two temperatures were compared by flow cytometry. Four MAbs have distinctly increased reactivity at 0 to 2 degrees C compared to 23 degrees C. HlyA requires HlyC-dependent acylation at lysine residues 563 and 689 for lytic function. Toxin with cysteine substitution mutations at each lysine (HlyA(K563C) and HlyA(K689C)) as well as the nonacylated form of hemolysin made in a HlyC-deficient strain were examined by flow cytometry at 0 to 2 and 23 degrees C. The three mutants bind erythrocytes at wild-type toxin levels, but there are conformational changes reflected by altered MAb epitope accessibility for six of the MAbs. To test further the surface accessibility of regions in the vicinity of MAb-reactive epitopes, HlyA(E) was proteolytically treated prior to testing for MAb reactivity. Differences in protease susceptibility at 0 to 2 degrees and 23 degrees C for the reactivities of three of the MAbs further support the model of two distinct conformations of cell-associated toxin.

Full Text

The Full Text of this article is available as a PDF (287.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer M. E., Welch R. A. Association of RTX toxins with erythrocytes. Infect Immun. 1996 Nov;64(11):4665–4672. doi: 10.1128/iai.64.11.4665-4672.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benz R., Döbereiner A., Ludwig A., Goebel W. Haemolysin of Escherichia coli: comparison of pore-forming properties between chromosome and plasmid-encoded haemolysins. FEMS Microbiol Immunol. 1992 Sep;5(1-3):55–62. doi: 10.1111/j.1574-6968.1992.tb05887.x. [DOI] [PubMed] [Google Scholar]
  3. Bhakdi S., Tranum-Jensen J. Membrane damage by pore-forming bacterial cytolysins. Microb Pathog. 1986 Feb;1(1):5–14. doi: 10.1016/0882-4010(86)90027-6. [DOI] [PubMed] [Google Scholar]
  4. Boehm D. F., Welch R. A., Snyder I. S. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes. Infect Immun. 1990 Jun;58(6):1959–1964. doi: 10.1128/iai.58.6.1959-1964.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen L., Coleman W. G., Jr Cloning and characterization of the Escherichia coli K-12 rfa-2 (rfaC) gene, a gene required for lipopolysaccharide inner core synthesis. J Bacteriol. 1993 May;175(9):2534–2540. doi: 10.1128/jb.175.9.2534-2540.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Economou A., Hamilton W. D., Johnston A. W., Downie J. A. The Rhizobium nodulation gene nodO encodes a Ca2(+)-binding protein that is exported without N-terminal cleavage and is homologous to haemolysin and related proteins. EMBO J. 1990 Feb;9(2):349–354. doi: 10.1002/j.1460-2075.1990.tb08117.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Felmlee T., Pellett S., Welch R. A. Nucleotide sequence of an Escherichia coli chromosomal hemolysin. J Bacteriol. 1985 Jul;163(1):94–105. doi: 10.1128/jb.163.1.94-105.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Felmlee T., Welch R. A. Alterations of amino acid repeats in the Escherichia coli hemolysin affect cytolytic activity and secretion. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5269–5273. doi: 10.1073/pnas.85.14.5269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Issartel J. P., Koronakis V., Hughes C. Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation. Nature. 1991 Jun 27;351(6329):759–761. doi: 10.1038/351759a0. [DOI] [PubMed] [Google Scholar]
  10. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ludwig A., Garcia F., Bauer S., Jarchau T., Benz R., Hoppe J., Goebel W. Analysis of the in vivo activation of hemolysin (HlyA) from Escherichia coli. J Bacteriol. 1996 Sep;178(18):5422–5430. doi: 10.1128/jb.178.18.5422-5430.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ludwig A., Jarchau T., Benz R., Goebel W. The repeat domain of Escherichia coli haemolysin (HlyA) is responsible for its Ca2+-dependent binding to erythrocytes. Mol Gen Genet. 1988 Nov;214(3):553–561. doi: 10.1007/BF00330494. [DOI] [PubMed] [Google Scholar]
  13. Ludwig A., Schmid A., Benz R., Goebel W. Mutations affecting pore formation by haemolysin from Escherichia coli. Mol Gen Genet. 1991 Apr;226(1-2):198–208. doi: 10.1007/BF00273604. [DOI] [PubMed] [Google Scholar]
  14. Ludwig A., Vogel M., Goebel W. Mutations affecting activity and transport of haemolysin in Escherichia coli. Mol Gen Genet. 1987 Feb;206(2):238–245. doi: 10.1007/BF00333579. [DOI] [PubMed] [Google Scholar]
  15. Menestrina G., Bashford C. L., Pasternak C. A. Pore-forming toxins: experiments with S. aureus alpha-toxin, C. perfringens theta-toxin and E. coli haemolysin in lipid bilayers, liposomes and intact cells. Toxicon. 1990;28(5):477–491. doi: 10.1016/0041-0101(90)90292-f. [DOI] [PubMed] [Google Scholar]
  16. Moayeri M., Welch R. A. Effects of temperature, time, and toxin concentration on lesion formation by the Escherichia coli hemolysin. Infect Immun. 1994 Oct;62(10):4124–4134. doi: 10.1128/iai.62.10.4124-4134.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pellett S., Boehm D. F., Snyder I. S., Rowe G., Welch R. A. Characterization of monoclonal antibodies against the Escherichia coli hemolysin. Infect Immun. 1990 Mar;58(3):822–827. doi: 10.1128/iai.58.3.822-827.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stanley P., Packman L. C., Koronakis V., Hughes C. Fatty acylation of two internal lysine residues required for the toxic activity of Escherichia coli hemolysin. Science. 1994 Dec 23;266(5193):1992–1996. doi: 10.1126/science.7801126. [DOI] [PubMed] [Google Scholar]
  19. Welch R. A., Dellinger E. P., Minshew B., Falkow S. Haemolysin contributes to virulence of extra-intestinal E. coli infections. Nature. 1981 Dec 17;294(5842):665–667. doi: 10.1038/294665a0. [DOI] [PubMed] [Google Scholar]
  20. Welch R. A. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol. 1991 Mar;5(3):521–528. doi: 10.1111/j.1365-2958.1991.tb00723.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES